Discrepancies in fosfomycin susceptibility testing of KPC-producing Klebsiella pneumoniae with various commercial methods
- 31 July 2018
- journal article
- research article
- Published by Elsevier BV in Diagnostic Microbiology and Infectious Disease
- Vol. 93 (1), 74-76
- https://doi.org/10.1016/j.diagmicrobio.2018.07.014
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Fosfomycin Susceptibility in Carbapenem-Resistant Enterobacteriaceae from GermanyJournal of Clinical Microbiology, 2014
- Fosfomycin for the Treatment of Resistant Gram-Negative Bacterial InfectionsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2014
- Susceptibility of Multiresistant Gram-Negative Bacteria to Fosfomycin and Performance of Different Susceptibility Testing MethodsAntimicrobial Agents and Chemotherapy, 2014
- Fosfomycin Trometamol: A Review of Its Use as a Single-Dose Oral Treatment for Patients with Acute Lower Urinary Tract Infections and Pregnant Women with Asymptomatic BacteriuriaDrugs, 2013
- Abatacept: A Review of its Use in the Management of Rheumatoid ArthritisDrugs, 2013
- Global Spread of Carbapenemase-producingEnterobacteriaceaeEmerging Infectious Diseases, 2011
- The revival of fosfomycinInternational Journal of Infectious Diseases, 2011
- Synergy of fosfomycin with carbapenems, colistin, netilmicin, and tigecycline against multidrug-resistant Klebsiella pneumoniae, Escherichia coli, and Pseudomonas aeruginosa clinical isolatesEuropean Journal of Clinical Microbiology & Infectious Diseases, 2011
- In Vitro Activity of Fosfomycin against bla KPC -Containing Klebsiella pneumoniae Isolates, Including Those Nonsusceptible to Tigecycline and/or ColistinAntimicrobial Agents and Chemotherapy, 2010
- In Vitro Activity of Fosfomycin against Extended-Spectrum-β-Lactamase- Producing Escherichia coli and Klebsiella pneumoniae : Comparison of Susceptibility Testing ProceduresAntimicrobial Agents and Chemotherapy, 2006